To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Ketorolac as an Adjuvant for Postoperative Pain Control After Arthroscopic Rotator Cuff Repair

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2021

Ketorolac as an Adjuvant for Postoperative Pain Control After Arthroscopic Rotator Cuff Repair

Vol: 109| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Oral Ketorolac as an Adjuvant Agent for Postoperative Pain Control After Arthroscopic Rotator Cuff Repair: A Prospective, Randomized, Controlled Study

J Am Acad Orthop Surg . 2021 May 28.

Contributing Authors:
L Sivasundaram S Mengers NN Trivedi J Strony MJ Salata JE Voos BN Victoroff, MR Karns RJ Gillespie

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Forty three patients undergoing arthroscopic rotator cuff repair were randomized to receive ketorolac (n=23) or control (n=20) in addition to standard postoperative analgesia. The outcomes of interest were postoperative pain control, opioid consumption, functional outcomes, adverse events and retear rates. The ketorolac group consumed significantly fewer narcotic pills and required less narcotic p...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue